C - Chemistry – Metallurgy – 12 – N
Patent
C - Chemistry, Metallurgy
12
N
C12N 15/12 (2006.01) A61K 48/00 (2006.01) C07K 14/475 (2006.01) C07K 14/50 (2006.01) C12N 15/86 (2006.01)
Patent
CA 2370404
The invention concerns the use of a vector comprising a nucleic acid encoding an angiogenic factor for preventing, improving and/or treating pulmonary hypertension.
La présente invention concerne l'utilisation d'un vecteur comprenant un acide nucléique codant pour un facteur angiogénique pour la prévention, l'amélioration et/ou le traitement de l'hypertension artérielle pulmonaire.
Adnot Serge
Branellec Didier
Aventis Pharma S.a.
Institut National de La Sante Et de La Recherche Medicale (inser
Robic
LandOfFree
Use of a recombinant defective adenovirus comprising a... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Use of a recombinant defective adenovirus comprising a..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Use of a recombinant defective adenovirus comprising a... will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1860480